Kathryn Baxstrom, MD
Hematology & Oncology · Saint Paul, MNNPI 1386987535
Payments from drug & device makers
What this record shows
This record is dominated by education: $58 of the $83 with a category attached, or 70.0%. 4 manufacturers reported payments, led by Daiichi Sankyo Inc. at 32.4% of the total. 2024 is the largest year on record at $52, 2.7 times the $19 reported in 2020. That places this record below the midpoint for hematology & oncology clinicians in MN, where the typical reported total is $238.
Across 4 payments — averaging $20.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$27
- Boehringer Ingelheim$25
- E.r. Squibb & Sons, L.L.C.$19
- Gilead$12
What the payments were for
- Food & beverage$2530%
- Education$5870%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 1 | $27 |
| Boehringer Ingelheim | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Gilead | 1 | $12 |
How this compares
$83 in reported general payments places this provider in the 25th percentile of 193 hematology & oncology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VerzenioAbemaciclib | 13 | $216,756 |
| EliquisApixaban | 31 | $29,451 |
| Abiraterone Acetate | 39 | $12,464 |
| Tamoxifen Citrate | 77 | $3,741 |
| Letrozole | 131 | $3,723 |
| Klor-Con M20Potassium Chloride | 19 | $1,099 |
| Exemestane | 11 | $1,015 |
| Hydroxyurea | 21 | $670 |
| Anastrozole | 19 | $537 |
| Acyclovir | 21 | $485 |
| Prochlorperazine Maleate | 21 | $441 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $336 |
| Dexamethasone | 39 | $324 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $324 |
| Oxycodone Hcl | 16 | $229 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Saint Paul
- Yan JiSaint Paul$164K
- Kurt DemelSaint Paul$22K
- Daniel AndersonSaint Paul$5K
- Charlene FaresSaint Paul$4K
- Mark RedingMinneapolis$519K
- Shilpa GuptaMinneapolis$421K
- Sagar PatelEdina$389K
- Vicki MorrisonMinneapolis$354K
- Deepti BehlRochester$205K
- Aimee MerinoMinneapolis$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.